| Peer-Reviewed

The Cytotoxicity of Analogues Carnosine Dipeptide on Human Glioblastoma Multiforme

Received: 8 October 2022     Accepted: 10 November 2022     Published: 13 January 2023
Views:       Downloads:
Abstract

Background & Aims: The present study evaluated the effect of some synthesized linear and cyclic Carnosine analogues on the cells of human glioblastoma multiforme (GBM). The purpose of this research was to study the exposure of Carnosin analogues on astrocytoma using several experiments. Methods: The mass spectral measurements were performed on a 6410 Agilent LCMS triple quadrupole mass spectrometer (LCMS) with an electrospray ionization (ESI) interface. All tests were carried out six times. The concentration used for peptides (10 µg/mL) was selected based on MTT assay. The effect of peptides on the activity of SDH was assayed by MTT test. 100 μL mitochondrial suspension from GBM and normal groups were incubated with applied concentration of peptides (10μg/mL) at 37°C for 30 min. DCFH (final concentration, 10µM) was added to cells of both groups and incubated at 37°C for 15 min. The fluorescence intensity of DCFH which is an indicator of ROS concentration was then assayed by a Shimadzu RF-5000U fluorescence spectrophotometer. The cationic fluorescent dye, rhodamine 123 (concentration10 µM), from mitochondria into the cytosol have been used for the determination of MMP collapse. Mitochondria from astrocytoma and normal astocyte groups were suspended in corresponding assay buffer and incubated at 37°C with 10µg/mL peptides. The release was assayed by the Quantikine Cytochrome c. Carnosine peptide analogues on the activation of caspase-3 in the mitochondria isolated from GBM and normal groups using Sigma’s caspase-3 colorimetric assay kit. Results: Our study showed that a various range of toxicity on GBM cells was resulted by the linear and cyclic Carnosine analogues using MTT assay. Also, applying peptides on the mitochondria of GBM cells, a raise of mitochondrial reactive oxygen species (ROS) level, mitochondrial swelling, mitochondrial membrane potential (∆ψm) collapse, release of cytochrome c and caspase-3 activation of the affected mitochondria were detected. Conclusion: Based on the overall results, cyclic Carnosine analogues, especially compound 1c [Cyclo-(β-alanine-¬His-Pro-¬β-alanine-¬His)] showed more toxic activity than linear Carnosine analogues, which would be supporting to develop Carnosine cyclic peptide analogues as new anticancer and complementary therapeutic agents for the treatment of glioblastoma.

Published in International Journal of Pharmacy and Chemistry (Volume 8, Issue 6)
DOI 10.11648/j.ijpc.20220806.11
Page(s) 67-74
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2023. Published by Science Publishing Group

Keywords

Human Glioblastoma, Cytotoxicity, Mitochondria, Linear and Cyclic Peptides

References
[1] Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A (2007) The 2007 WHO classification of tumours of the central nervous system. Acta neuropathologica 114: 97-109.
[2] Verkhratsky A, Butt A (2013) glial physiology and pathophysiology, John Wiley & Sons, Ltd,. pp 1-560.
[3] Houben M, Coebergh J, Birch J, Tijssen C, van Duijn C, McNally R (2006) Space–time clustering of glioma cannot be attributed to specific histological subgroups. European journal of epidemiology 21: 197-201.
[4] Mitsuya K, Nakasu Y, Horiguchi S, Harada H, Nishimura T, Bando E et al (2010) Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery. Journal of neuro-oncology 99: 81-8.
[5] Bleeker FE, Molenaar RJ, Leenstra S (2012) Recent advances in the molecular understanding of glioblastoma. Journal of neuro-oncology 108: 11-27.
[6] Young RM, Jamshidi A, Davis G, Sherman JH (2015) Current trends in the surgical management and treatment of adult glioblastoma. Annals of translational medicine 3: 121.
[7] Khosla D (2016) Concurrent therapy to enhance radiotherapeutic outcomes in glioblastoma. Annals of translational medicine 4: 54.
[8] Hart MG, Garside R, Rogers G, Stein K, Grant R (2013) Temozolomide for high grade glioma. The Cochrane Library 30: 1-58.
[9] Davey C (1960) The effects of carnosine and anserine on glycolytic reactions in skeletal muscle. Archives of Biochemistry and Biophysics 89: 296-302.
[10] Snyder SH (1980) Brain peptides as neurotransmitters. Science 209: 976-83.
[11] Brown CE (1981) Interactions among carnosine, anserine, ophidine and copper in biochemical adaptation. Journal of Theoretical Biology 88: 245-56.
[12] Hipkiss AR, Michaelis J, Syrris P (1995) Non-enzymatic glycosylation of the dipeptide L-carnosine, a potential anti-protein-cross-linking agent. FEBS letters 371: 81-5.
[13] Aruoma OI, Laughton MJ, Halliwell B (1989) Carnosine, homocarnosine and anserine: could they act as antioxidants in vivo? Biochemical Journal 264: 863-9.
[14] Babizhayev MA, Seguin M, Gueyne J, Evstigneeva R, Ageyeva E, Zheltukhina G (1994) L-Carnosine (β-alanyl-L-histidine) and carcinine (β-alanylhistamine) act as natural antioxidants with hydroxyl-radical-scavenging and lipid-peroxidase activities. Biochemical journal 304: 509-16.
[15] Hipkiss AR, Worthington VC, Himsworth DT, Herwig W (1998) Protective effects of carnosine against protein modification mediated by malondialdehyde and hypochlorite. Biochimica et Biophysica Acta 1380: 46-54.
[16] Kohen R, Yamamoto Y, Cundy KC, Ames BN (1988) Antioxidant activity of carnosine, homocarnosine, and anserine present in muscle and brain. Proceedings of the National Academy of Sciences 85: 3175-9.
[17] Boldyrev A, Dupin A, Bunin A, Babizhaev M, Severin S (1987) The antioxidative properties of carnosine, a natural histidine containing dipeptide. Biochemistry international 15: 1105.
[18] Choi SY, Kwon HY, Kwon OB, Kang JH (1999) Hydrogen peroxide-mediated Cu, Zn-superoxide dismutase fragmentation: protection by carnosine, homocarnosine and anserine. Biochimica et Biophysica Acta 1472: 651-7.
[19] Nagai K, Suda T, Kawasaki K, Mathuura S (1986) Action of carnosine and â-alanine on wound healing. Surgery 100: 815-21.
[20] Renner C, Seyffarth A, de Arriba SG, Meixensberger J, Gebhardt R, Gaunitz F et al (2008) Carnosine inhibits growth of cells isolated from human glioblastoma multiforme. International Journal of Peptide Research and Therapeutics 14: 127-35.
[21] Renner C, Asperger A, Seyffarth A, Meixensberger J, Gebhardt R, Gaunitz F et al (2010) Carnosine inhibits ATP production in cells from malignant glioma. Neurological research 32: 101-5.
[22] Iovine B, Oliviero G, Garofalo M, Orefice M, Nocella F, Borbone N et al (2014) The anti-proliferative effect of L-carnosine correlates with a decreased expression of hypoxia inducible factor 1 alpha in human colon cancer cells. PloS one 9: e96755.
[23] Renner C, Zemitzsch N, Fuchs B, Geiger KD, Hermes M, Hengstler J et al (2010) Carnosine retards tumor growth in vivo in an NIH3T3-HER2/neu mouse model. Molecular cancer 9: 2.
[24] Horii Y, Shen J, Fujisaki Y, Yoshida K, Nagai K (2012) Effects of l-carnosine on splenic sympathetic nerve activity and tumor proliferation. Neuroscience letters 510: 1-5.
[25] Seydi E, Motallebi A, Dastbaz M, Dehghan S, Salimi A, Nazemi M (2015) Selective toxicity of persian gulf sea cucumber (Holothuria parva) and sponge (Haliclona oculata) methanolic extracts on liver mitochondria isolated from an animal model of hepatocellular carcinoma. Hepatitis monthly 15: e33073.
[26] Talari M, Seydi E, Salimi A, Mohsenifar Z, Kamalinejad M, Pourahmad J (2014) Dracocephalum: novel anticancer plant acting on liver cancer cell mitochondria. BioMed research international 2014: 1-10.
[27] Jain D, Kumar S (2012) Snake venom: a potent anticancer agent. Asian Pac J Cancer Prev 13: 4855-60.
[28] Salimi A, Roudkenar MH, Sadeghi L, Mohseni A, Seydi E, Pirahmadi N et al (2015) Ellagic acid, a polyphenolic compound, selectively induces ROS-mediated apoptosis in cancerous B-lymphocytes of CLL patients by directly targeting mitochondria. Redox biology 6: 461-71.
[29] Enayatollah S, Amir Hosseini S, Salimi A, Pourahmad J (2016) Propolis induce cytotoxicity on cancerous hepatocytes isolated from rat model of hepatocellular carcinoma: Involvement of ROS-mediated mitochondrial targeting. Pharma nutrition 4: 143-150.
[30] Begnini KR, Moura de Leon PM, Thurow H, Schultze E, Campos VF, Martins Rodrigues F et al (2014) Brazilian red propolis induces apoptosis-like cell death and decreases migration potential in bladder cancer cells. Evidence-Based Complementary and Alternative Medicine 2014: 1-13.
[31] Gaunitz F, Hipkiss AR (2012) Carnosine and cancer: a perspective. Amino Acids 43: 135–142.
Cite This Article
  • APA Style

    Mohammadreza Gholibeikian, Nastaran Gholami Samali, Amirreza Arvaneh. (2023). The Cytotoxicity of Analogues Carnosine Dipeptide on Human Glioblastoma Multiforme. International Journal of Pharmacy and Chemistry, 8(6), 67-74. https://doi.org/10.11648/j.ijpc.20220806.11

    Copy | Download

    ACS Style

    Mohammadreza Gholibeikian; Nastaran Gholami Samali; Amirreza Arvaneh. The Cytotoxicity of Analogues Carnosine Dipeptide on Human Glioblastoma Multiforme. Int. J. Pharm. Chem. 2023, 8(6), 67-74. doi: 10.11648/j.ijpc.20220806.11

    Copy | Download

    AMA Style

    Mohammadreza Gholibeikian, Nastaran Gholami Samali, Amirreza Arvaneh. The Cytotoxicity of Analogues Carnosine Dipeptide on Human Glioblastoma Multiforme. Int J Pharm Chem. 2023;8(6):67-74. doi: 10.11648/j.ijpc.20220806.11

    Copy | Download

  • @article{10.11648/j.ijpc.20220806.11,
      author = {Mohammadreza Gholibeikian and Nastaran Gholami Samali and Amirreza Arvaneh},
      title = {The Cytotoxicity of Analogues Carnosine Dipeptide on Human Glioblastoma Multiforme},
      journal = {International Journal of Pharmacy and Chemistry},
      volume = {8},
      number = {6},
      pages = {67-74},
      doi = {10.11648/j.ijpc.20220806.11},
      url = {https://doi.org/10.11648/j.ijpc.20220806.11},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijpc.20220806.11},
      abstract = {Background & Aims: The present study evaluated the effect of some synthesized linear and cyclic Carnosine analogues on the cells of human glioblastoma multiforme (GBM). The purpose of this research was to study the exposure of Carnosin analogues on astrocytoma using several experiments. Methods: The mass spectral measurements were performed on a 6410 Agilent LCMS triple quadrupole mass spectrometer (LCMS) with an electrospray ionization (ESI) interface. All tests were carried out six times. The concentration used for peptides (10 µg/mL) was selected based on MTT assay. The effect of peptides on the activity of SDH was assayed by MTT test. 100 μL mitochondrial suspension from GBM and normal groups were incubated with applied concentration of peptides (10μg/mL) at 37°C for 30 min. DCFH (final concentration, 10µM) was added to cells of both groups and incubated at 37°C for 15 min. The fluorescence intensity of DCFH which is an indicator of ROS concentration was then assayed by a Shimadzu RF-5000U fluorescence spectrophotometer. The cationic fluorescent dye, rhodamine 123 (concentration10 µM), from mitochondria into the cytosol have been used for the determination of MMP collapse. Mitochondria from astrocytoma and normal astocyte groups were suspended in corresponding assay buffer and incubated at 37°C with 10µg/mL peptides. The release was assayed by the Quantikine Cytochrome c. Carnosine peptide analogues on the activation of caspase-3 in the mitochondria isolated from GBM and normal groups using Sigma’s caspase-3 colorimetric assay kit. Results: Our study showed that a various range of toxicity on GBM cells was resulted by the linear and cyclic Carnosine analogues using MTT assay. Also, applying peptides on the mitochondria of GBM cells, a raise of mitochondrial reactive oxygen species (ROS) level, mitochondrial swelling, mitochondrial membrane potential (∆ψm) collapse, release of cytochrome c and caspase-3 activation of the affected mitochondria were detected. Conclusion: Based on the overall results, cyclic Carnosine analogues, especially compound 1c [Cyclo-(β-alanine-¬His-Pro-¬β-alanine-¬His)] showed more toxic activity than linear Carnosine analogues, which would be supporting to develop Carnosine cyclic peptide analogues as new anticancer and complementary therapeutic agents for the treatment of glioblastoma.},
     year = {2023}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - The Cytotoxicity of Analogues Carnosine Dipeptide on Human Glioblastoma Multiforme
    AU  - Mohammadreza Gholibeikian
    AU  - Nastaran Gholami Samali
    AU  - Amirreza Arvaneh
    Y1  - 2023/01/13
    PY  - 2023
    N1  - https://doi.org/10.11648/j.ijpc.20220806.11
    DO  - 10.11648/j.ijpc.20220806.11
    T2  - International Journal of Pharmacy and Chemistry
    JF  - International Journal of Pharmacy and Chemistry
    JO  - International Journal of Pharmacy and Chemistry
    SP  - 67
    EP  - 74
    PB  - Science Publishing Group
    SN  - 2575-5749
    UR  - https://doi.org/10.11648/j.ijpc.20220806.11
    AB  - Background & Aims: The present study evaluated the effect of some synthesized linear and cyclic Carnosine analogues on the cells of human glioblastoma multiforme (GBM). The purpose of this research was to study the exposure of Carnosin analogues on astrocytoma using several experiments. Methods: The mass spectral measurements were performed on a 6410 Agilent LCMS triple quadrupole mass spectrometer (LCMS) with an electrospray ionization (ESI) interface. All tests were carried out six times. The concentration used for peptides (10 µg/mL) was selected based on MTT assay. The effect of peptides on the activity of SDH was assayed by MTT test. 100 μL mitochondrial suspension from GBM and normal groups were incubated with applied concentration of peptides (10μg/mL) at 37°C for 30 min. DCFH (final concentration, 10µM) was added to cells of both groups and incubated at 37°C for 15 min. The fluorescence intensity of DCFH which is an indicator of ROS concentration was then assayed by a Shimadzu RF-5000U fluorescence spectrophotometer. The cationic fluorescent dye, rhodamine 123 (concentration10 µM), from mitochondria into the cytosol have been used for the determination of MMP collapse. Mitochondria from astrocytoma and normal astocyte groups were suspended in corresponding assay buffer and incubated at 37°C with 10µg/mL peptides. The release was assayed by the Quantikine Cytochrome c. Carnosine peptide analogues on the activation of caspase-3 in the mitochondria isolated from GBM and normal groups using Sigma’s caspase-3 colorimetric assay kit. Results: Our study showed that a various range of toxicity on GBM cells was resulted by the linear and cyclic Carnosine analogues using MTT assay. Also, applying peptides on the mitochondria of GBM cells, a raise of mitochondrial reactive oxygen species (ROS) level, mitochondrial swelling, mitochondrial membrane potential (∆ψm) collapse, release of cytochrome c and caspase-3 activation of the affected mitochondria were detected. Conclusion: Based on the overall results, cyclic Carnosine analogues, especially compound 1c [Cyclo-(β-alanine-¬His-Pro-¬β-alanine-¬His)] showed more toxic activity than linear Carnosine analogues, which would be supporting to develop Carnosine cyclic peptide analogues as new anticancer and complementary therapeutic agents for the treatment of glioblastoma.
    VL  - 8
    IS  - 6
    ER  - 

    Copy | Download

Author Information
  • Department of Organic Chemistry, Faculty of Chemistry, University of Kashan, Kashan, I. R. Iran

  • Department of Analytical Chemistry, Faculty of Chemistry, Shahid Chamran University of Ahvaz, Ahvaz, Iran

  • Department of Organic Chemistry, Faculty of Chemistry, University of Science and Technology, Tehran, I. R. Iran

  • Sections